The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study

BACKGROUND: There is no standard neoadjuvant therapy for locally advanced esophageal cancer in China. The role of neoadjuvant chemotherapy plus immunotherapy for locally advanced esophageal cancer is still being explored. METHODS: This open-label, randomized phase II study was conducted at a single...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Wenqun, Zhao, Lingdi, Zheng, Yan, Liu, Baoxing, Liu, Xianben, Li, Tiepeng, Zhang, Yong, Ma, Baozhen, Yang, Yonghao, Shang, Yiman, Fu, Xiaomin, Liang, Guanghui, Yuan, Dongfeng, Qu, Jinrong, Chai, Xiaofei, Zhang, He, Wang, Zibing, Lin, Hongwei, Liu, Liang, Ren, Xiubao, Zhang, Jiangong, Gao, Quanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685246/
https://www.ncbi.nlm.nih.gov/pubmed/34938292
http://dx.doi.org/10.3389/fimmu.2021.772450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685246/
https://www.ncbi.nlm.nih.gov/pubmed/34938292
http://dx.doi.org/10.3389/fimmu.2021.772450

Ejemplares similares